Skip to main content
Top
Published in: Forensic Science, Medicine and Pathology 2/2013

01-06-2013 | Case Report

Lethal neuroleptic malignant syndrome due to amisulpride

Authors: Frank Musshoff, Elke Doberentz, Burkhard Madea

Published in: Forensic Science, Medicine and Pathology | Issue 2/2013

Login to get access

Abstract

A 42-year old-man was found lying in his bed having seizures. Later he became unconscious and hypotonic developing mydriasis as well as rigidity. The body core temperature (rectal temperature) was above 42 °C. Blood pH was decreased during treatment, and his general condition deteriorated. The patient developed gasping respiration, ventricular fibrillation, and died. During autopsy and histological investigation cerebral and pulmonary edema were noted together with general congestion of the internal organs. Further observations included contraction bands of myocytes, a contracted spleen, fibrosis of the liver, and gall stones. Toxicological analyses of peripheral blood revealed the following results: amisulpride 4.65 mg/l, biperiden 0.12 mg/l, imipramine 0.33 mg/l, and desipramine 0.68 mg/l. An amisulpride-induced neuroleptic malignant syndrome was therefore diagnosed as the patho-physiological mechanism leading to death.
Literature
1.
go back to reference Trollor JN, Chen X, Sachdev PS. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS Drugs. 2009;23:477–92.PubMedCrossRef Trollor JN, Chen X, Sachdev PS. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS Drugs. 2009;23:477–92.PubMedCrossRef
2.
go back to reference Guzofski S, Peralta R. Neuroleptic malignant syndrome, with attention to its occurrence with atypical antipsychotic medication: a review. Jeff J Psych. 2006;20(1):54–61. Guzofski S, Peralta R. Neuroleptic malignant syndrome, with attention to its occurrence with atypical antipsychotic medication: a review. Jeff J Psych. 2006;20(1):54–61.
3.
go back to reference Addonizio G, Susman VL, Roth SD. Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. Am J Psychiatry. 1986;143:1587–90.PubMed Addonizio G, Susman VL, Roth SD. Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. Am J Psychiatry. 1986;143:1587–90.PubMed
4.
go back to reference American Psychiatric Association. Diagnostic and statistical manual. 4th ed. (text revision). Arlington, VA: American Psychiatric Publishing; 2000. American Psychiatric Association. Diagnostic and statistical manual. 4th ed. (text revision). Arlington, VA: American Psychiatric Publishing; 2000.
5.
go back to reference Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry. 1985;142:1137–45.PubMed Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry. 1985;142:1137–45.PubMed
6.
go back to reference Musshoff F, Kröner L, Padosch SA, Madea B. Fatal intoxication with amisulpride and presentation of organ distribution. Arch Kriminol. 2005;215:158–63.PubMed Musshoff F, Kröner L, Padosch SA, Madea B. Fatal intoxication with amisulpride and presentation of organ distribution. Arch Kriminol. 2005;215:158–63.PubMed
7.
go back to reference Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1000 drugs and other xenobiotics. Crit Care. 2012;16(4):R136.PubMedCrossRef Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1000 drugs and other xenobiotics. Crit Care. 2012;16(4):R136.PubMedCrossRef
8.
go back to reference Tracqui A, Mutter-Schmidt C, Kintz P, Berton C, Mangin P. Amisulpride poisoning: a report on two cases. Hum Exp Toxicol. 1995;14:294–8.PubMedCrossRef Tracqui A, Mutter-Schmidt C, Kintz P, Berton C, Mangin P. Amisulpride poisoning: a report on two cases. Hum Exp Toxicol. 1995;14:294–8.PubMedCrossRef
9.
go back to reference Isbister GK, Murray L, John S, Hackett LP, Haider T, O’Mullane P, Gosselin S, Daly F. Amisulpride deliberate self-poisoning causing severe cardiac toxicity including QT prolongation and torsades de pointes. Med J Aust. 2006;184:354–6.PubMed Isbister GK, Murray L, John S, Hackett LP, Haider T, O’Mullane P, Gosselin S, Daly F. Amisulpride deliberate self-poisoning causing severe cardiac toxicity including QT prolongation and torsades de pointes. Med J Aust. 2006;184:354–6.PubMed
10.
go back to reference Lynch MJ, Woods J, George N, Gerostamoulos D. Fatality due to amisulpride toxicity: a case report. Med Sci Law. 2008;48:173–7.PubMedCrossRef Lynch MJ, Woods J, George N, Gerostamoulos D. Fatality due to amisulpride toxicity: a case report. Med Sci Law. 2008;48:173–7.PubMedCrossRef
11.
go back to reference Curran MP, Perry CM. Amisulpride: a review of its use in the management of schizophrenia. Drugs. 2001;61:2123–50.PubMedCrossRef Curran MP, Perry CM. Amisulpride: a review of its use in the management of schizophrenia. Drugs. 2001;61:2123–50.PubMedCrossRef
12.
go back to reference Rosenzweig P, Canal M, Patat A, Bergougnan L, Zieleniuk I, Bianchetti G. A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers. Hum Psychopharmacol. 2002;17:1–13.PubMedCrossRef Rosenzweig P, Canal M, Patat A, Bergougnan L, Zieleniuk I, Bianchetti G. A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers. Hum Psychopharmacol. 2002;17:1–13.PubMedCrossRef
13.
go back to reference Dorne R, Pommier C, Manchon M, Berny C. Intoxication with amisulpride (Solian): a case with toxicologic documentations. Therapie. 2000;55:325–8.PubMed Dorne R, Pommier C, Manchon M, Berny C. Intoxication with amisulpride (Solian): a case with toxicologic documentations. Therapie. 2000;55:325–8.PubMed
14.
go back to reference Bottlender R, Jager M, Hofschuster E, Dobmeier P, Moller HJ. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient. Pharmacopsychiatry. 2002;35:119–21.PubMedCrossRef Bottlender R, Jager M, Hofschuster E, Dobmeier P, Moller HJ. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient. Pharmacopsychiatry. 2002;35:119–21.PubMedCrossRef
15.
go back to reference Atbasoglu EC, Ozguven HD, Can Saka M, Goker C. Rhabdomyolysis and coma associated with amisulpride: a probable atypical presentation of neuroleptic malignant syndrome. J Clin Psychiatry. 2004;65(12):1724–5.PubMedCrossRef Atbasoglu EC, Ozguven HD, Can Saka M, Goker C. Rhabdomyolysis and coma associated with amisulpride: a probable atypical presentation of neuroleptic malignant syndrome. J Clin Psychiatry. 2004;65(12):1724–5.PubMedCrossRef
16.
go back to reference Abay E, Kose R. Amisulpride-induced neuroleptic malignant syndrome. J Neuropsychiatry Clin Neurosci. 2007;19:488–9.PubMedCrossRef Abay E, Kose R. Amisulpride-induced neuroleptic malignant syndrome. J Neuropsychiatry Clin Neurosci. 2007;19:488–9.PubMedCrossRef
17.
go back to reference Harter C, Obier C, Druschky KF, Eikelmann B. Malignant neuroleptic syndrome associated with amisulpride. Nervenarzt. 2008;79:86–9.PubMedCrossRef Harter C, Obier C, Druschky KF, Eikelmann B. Malignant neuroleptic syndrome associated with amisulpride. Nervenarzt. 2008;79:86–9.PubMedCrossRef
18.
go back to reference Peritogiannis V, Tsouli S, Pappas D, Mavreas V, Konitsiotis S. Neuroleptic malignant syndrome due to amisulpride in a patient with solvent-induced chronic toxic encephalopathy. Clin Neuropharmacol. 2007;30:245–6.PubMed Peritogiannis V, Tsouli S, Pappas D, Mavreas V, Konitsiotis S. Neuroleptic malignant syndrome due to amisulpride in a patient with solvent-induced chronic toxic encephalopathy. Clin Neuropharmacol. 2007;30:245–6.PubMed
19.
go back to reference Tu MC, Hsiao CC. Amisulpride and neuroleptic malignant syndrome. Chang Gung Med J. 2011;34:536–40.PubMed Tu MC, Hsiao CC. Amisulpride and neuroleptic malignant syndrome. Chang Gung Med J. 2011;34:536–40.PubMed
20.
go back to reference Pope HG Jr, Keck PE Jr, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry. 1986;143:1227–33.PubMed Pope HG Jr, Keck PE Jr, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry. 1986;143:1227–33.PubMed
21.
go back to reference Adityanjee PA. The spectrum concept and prevalence of neuroleptic malignant syndrome. Am J Psychiatry. 1988;145(8):1041.PubMed Adityanjee PA. The spectrum concept and prevalence of neuroleptic malignant syndrome. Am J Psychiatry. 1988;145(8):1041.PubMed
Metadata
Title
Lethal neuroleptic malignant syndrome due to amisulpride
Authors
Frank Musshoff
Elke Doberentz
Burkhard Madea
Publication date
01-06-2013
Publisher
Springer US
Published in
Forensic Science, Medicine and Pathology / Issue 2/2013
Print ISSN: 1547-769X
Electronic ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-013-9410-1

Other articles of this Issue 2/2013

Forensic Science, Medicine and Pathology 2/2013 Go to the issue